These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17414236)

  • 1. Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study.
    Black DW; Arndt S; Coryell WH; Argo T; Forbush KT; Shaw MC; Perry P; Allen J
    J Clin Psychopharmacol; 2007 Apr; 27(2):143-50. PubMed ID: 17414236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open-label trial of escitalopram in the treatment of pathological gambling.
    Black DW; Shaw M; Forbush KT; Allen J
    Clin Neuropharmacol; 2007; 30(4):206-12. PubMed ID: 17762317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bupropion hydrochloride in attention deficit disorder with hyperactivity.
    Conners CK; Casat CD; Gualtieri CT; Weller E; Reader M; Reiss A; Weller RA; Khayrallah M; Ascher J
    J Am Acad Child Adolesc Psychiatry; 1996 Oct; 35(10):1314-21. PubMed ID: 8885585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
    Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
    Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study.
    Wilens TE; Haight BR; Horrigan JP; Hudziak JJ; Rosenthal NE; Connor DF; Hampton KD; Richard NE; Modell JG
    Biol Psychiatry; 2005 Apr; 57(7):793-801. PubMed ID: 15820237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
    Levin FR; Evans SM; Brooks DJ; Kalbag AS; Garawi F; Nunes EV
    Drug Alcohol Depend; 2006 Feb; 81(2):137-48. PubMed ID: 16102908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
    Koran LM; Gamel NN; Choung HW; Smith EH; Aboujaoude EN
    J Clin Psychiatry; 2005 Apr; 66(4):515-20. PubMed ID: 15816795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study.
    Martenyi F; Brown EB; Caldwell CD
    J Clin Psychopharmacol; 2007 Apr; 27(2):166-70. PubMed ID: 17414240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.
    Grant JE; Kim SW; Odlaug BL
    Biol Psychiatry; 2007 Sep; 62(6):652-7. PubMed ID: 17445781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A; Korotzer A; Gommoll C; Li D
    Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
    Greist JH; Jefferson JW; Rosenfeld R; Gutzmann LD; March JS; Barklage NE
    J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label trial of acamprosate in the treatment of pathological gambling.
    Black DW; McNeilly DP; Burke WJ; Shaw MC; Allen J
    Ann Clin Psychiatry; 2011 Nov; 23(4):250-6. PubMed ID: 22073381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bupropion-SR in treatment of social phobia.
    Emmanuel NP; Brawman-Mintzer O; Morton WA; Book SW; Johnson MR; Lorberbaum JP; Ballenger JC; Lydiard RB
    Depress Anxiety; 2000; 12(2):111-3. PubMed ID: 11091936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended release carbamazepine in the treatment of pathological gambling: an open-label study.
    Black DW; Shaw MC; Allen J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1191-4. PubMed ID: 18436362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension.
    Thase ME; Haight BR; Johnson MC; Hunt T; Krishen A; Fleck RJ; Modell JG
    J Clin Psychopharmacol; 2008 Jun; 28(3):302-7. PubMed ID: 18480687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.